RECRUITING

Home Exercise for Individuals With Neurodegenerative Disease

Description

The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

Conditions

Neurodegenerative DiseasesLeukodystrophyAtaxiaLBSLLeukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder)Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate ElevationCerebellar AtaxiaAdrenomyeloneuropathy
Talk to us

Related Conditions:

Neurodegenerative DiseasesLeukodystrophyAtaxiaLBSLLeukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder)Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate ElevationCerebellar AtaxiaAdrenomyeloneuropathy

Study Overview

On this page

Study Details

Study overview

The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

Study of Adapted Exercise and Mindfulness Interventions to Improve Motor Function and Sleep Quality in Individuals With Neurodegenerative Disease

Home Exercise for Individuals With Neurodegenerative Disease

Condition
Neurodegenerative Diseases
Intervention / Treatment

-

Contacts and Locations

Baltimore

Kennedy Krieger Institute, Baltimore, Maryland, United States, 21205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * The eligibility criteria for males is X-linked adrenoleukodystrophy as determined by biochemical determination or genetic testing.
  • * The eligibility criteria for females is X-linked adrenoleukodystrophy as determined by biochemical determination, genetic testing, or pedigree analysis.
  • * The Leukoenceophalopathy with brainstem and spinal cord involvement and lactate elevation inclusion criterion is a confirmed DARS2 mutation through genetic analysis.
  • * For people with cerebellar ataxia, people with diagnoses of cerebellar damage from stroke, tumor or degeneration will be included. Those with a genetically confirmed cerebellar disorder will be asked to provide their genetic testing to note their particular type of ataxia.
  • * We will also include patients with other neurodegenerative diseases similar to these disorders as determined by chart review and clinical exam.
  • * Able to stand for 30 seconds without upper extremity support
  • * Ambulatory (including use of a cane or a walker)
  • * Able to walk for 2 minutes
  • * Other medical or psychological conditions which in the clinical judgement of the investigator would interfere with acquiring the study information or performing the exercises safely including but not limited to:

Ages Eligible for Study

5 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.,

Jennifer Keller, PT, PRINCIPAL_INVESTIGATOR, Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Study Record Dates

2027-07-30